SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Home on the range where the buffalo roam
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: horsegirl48 who wrote (7425)5/1/2002 2:15:52 PM
From: Venkie  Read Replies (2) of 13815
 
13:32 ET Merrill Lynch sees trading opportunity in tech, biotech
Merrill Lynch notes that a valuation gap has widened between the tech and biotech groups, which may present a trading opportunity; firm notes that the multiples of the two tend to trade in sync, and that whenever there is a divergence they tend to revert by either one group's multiple expanding or the other group's shrinking. The recent run-up in tech appears to have left the biotech multiples at the lower-end of its trading range, and if the theory holds, it is likely that the biotech space will play catch-up to the expansion in tech multiples.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News